A price slash for Coach (COH) may have investors thinking twice before picking up the handbag maker stock. Credit Suisse (CS) lowered its price target for Coach to $30 per share from $39 due to future sales. The firm is keeping its Neutral rating for the stock. But a brighter outlook for a glaucoma drug maker, Aerie Pharmaceuticals (AERI). Canaccord initiated coverage of the drugmaker with a buy rating and a price target set at $40 per share. And Jefferies is raising its price target for Toyota Motors (TM) to $139.80 per share. The firm is also reiterating its BUY rating for the stock. TheStreet's Susannah Lee has the details in today's Analysts' Actions from Wall Street.

More from Video

60 Seconds: What is the Yield Curve and Why is Everyone Talking About It?

60 Seconds: What is the Yield Curve and Why is Everyone Talking About It?

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

Millennials Love Investing in Timeshares: Bluegreen Vacations CEO

Millennials Love Investing in Timeshares: Bluegreen Vacations CEO

60 Seconds: What's the Difference Between an ETF and a Mutual Fund?

60 Seconds: What's the Difference Between an ETF and a Mutual Fund?

Amazon's One-Year Anniversary of Buying Whole Foods: A Whole Lot of Silly Hype

Amazon's One-Year Anniversary of Buying Whole Foods: A Whole Lot of Silly Hype